,,,so what are the scenarios on a partnership,,,,,,,,,,,double the share count??.....half the share count???,,,,,less??  ,,,,what is the cost of this next trial???,,,,,,,, $60-$80 million maybe?,,well that will add up to 50% more dilution,,,,,,,,what should we expect??,,,,,,,the market is no fool,,,,,it knows whats coming!!,,,,I will eat two crow pies and lick the plates if were to ever get to even $4 in the next year,,,,,cant see it,,,,,selling the company to Pharma is best case for existing shareholders....and then we could fail the BoM2,,,that would not surprise me one iota,,,,